Correction to: An estrogen antagonist, cyclofenil, has anti-dengue-virus activity (Archives of Virology, (2019), 164, 1, (225-234), 10.1007/s00705-018-4079-0)

Daiki Tohma, Shigeru Tajima, Fumihiro Kato, Hirotaka Sato, Michinori Kakisaka, Takayuki Hishiki, Michiyo Kataoka, Haruko Takeyama, Chang Kweng Lim, Yoko Aida, Masayuki Saijo

Research output: Contribution to journalComment/debatepeer-review

Abstract

We would like to correct the information on the antibody used in this study. In Fig. 5 of the article, cellular β-actin was detected as an internal control using anti-β-actin antibody (Fujifilm Wako Pure Chemicals, #017-24573). Recently, however, the manufacturer/provider informed us that the antibody reacts with cellular γ1-actin, but do not react with cellular β-actin. Consequently, we detected cellular γ1-actin molecules in the experiment. Fortunately, expression pattern of γ1-actin is similar to that of β-actin in most of cultured cells and, therefore, the alteration of the target molecules does not affect our interpretations and conclusions. The name of the antibody has been corrected in the paper. We apologize for any inconvenience and confusion caused by this error.

Original languageEnglish
Pages (from-to)235
Number of pages1
JournalArchives of Virology
Volume164
Issue number1
DOIs
Publication statusPublished - 2019 Jan 22

ASJC Scopus subject areas

  • Virology

Fingerprint

Dive into the research topics of 'Correction to: An estrogen antagonist, cyclofenil, has anti-dengue-virus activity (Archives of Virology, (2019), 164, 1, (225-234), 10.1007/s00705-018-4079-0)'. Together they form a unique fingerprint.

Cite this